Science Direct: Time outdoors and the prevention of myopia

8 October 2019
Source: Science Direct.

Amanda N.Frencha, Regan S,.Ashby, Ian G.Morgan, Kathryn A.Rose Highlights •  Children who spend more time outdoors are less likely to become myopic. •  This protection appears to be due to time outdoors, rather than engagement in sport. •  Effect sizes suggest that more time outdoors could reduce myopia in children. •  Dopamine release may be stimulated by bright outdoor light,

Read more Science Direct: Time outdoors and the prevention of myopia

Direction of Vision UK 2019

Vision UK logo

19 September 2019
Source: Vision UK

Following on from the Vision UK Leadership Panel meeting held in May 2019 and comments from the members, the direction of Vision UK document has been reviewed and amended. The direction of the future work of Vision UK is the continued development of the infrastructure organisation to better facilitate and encourage partnership and collaborative work, while allowing and encouraging members

Read more Direction of Vision UK 2019
Direction Of Vision UK
Direction Of Vision UK
Download docx 0.1 MB

Action Against AMD (AAAMD) partners with leading organisations and the UK Government to establish the Health Data Research Hub for Eye Health

13 September 2019
Source: AAAMD

AAAMD is a partner in INSIGHT – Health Data Research Hub for Eye Health. INSIGHT is one of the seven pioneering data research centres to enable cutting-edge research and innovation to benefit UK patients. There is an increasing demand for ‘big data’ to enable innovation in health technologies and improve patient care. INSIGHT creates an NHS-academic-industry partnership to make anonymised

Read more Action Against AMD (AAAMD) partners with leading organisations and the UK Government to establish the Health Data Research Hub for Eye Health

BBC News: Gene therapy for rare eye disease set to be offered on NHS

4 September 2019
Source: BBC News

Patients with a rare inherited eye disorder are set to be able to access a new gene therapy on the NHS which slows down sight loss. Draft NICE guidance recommends the therapy (Luxturna) to treat inherited retinal dystrophies. The National Institute for Health and Care Excellence estimates just under 90 people in England will be eligible for the treatment. Drug

Read more BBC News: Gene therapy for rare eye disease set to be offered on NHS

Fight for Sight and Royal College of Ophthalmologists: John Lee Primer Fellowship

22 August 2019
Source: Fight for Sight and Royal College of Ophthalmologists

Fight for Sight’s mission is to stop sight loss by funding the highest quality medical research and they are proud to collaborate with the Royal College of Ophthalmologists to help achieve this goal. The John Lee Primer Fellowship is designed to support early stage ophthalmologists to undertake ground-breaking vision research and represents the first step for ophthalmologists to obtain a

Read more Fight for Sight and Royal College of Ophthalmologists: John Lee Primer Fellowship

Fight for Sight: Examining the role of vitamin B3 supplementation in reducing and preventing retinal cell damage caused by glaucoma

20 August 2019

Fight for Sight is funding researchers at Cardiff University to examine the extent to which dietary supplementation of Nicotinamide – a form of vitamin B3 – can be used to reduce, and even prevent, retinal damage caused by glaucoma. This important research could help pave the way for new types of treatment for glaucoma, which are currently focused only on

Read more Fight for Sight: Examining the role of vitamin B3 supplementation in reducing and preventing retinal cell damage caused by glaucoma

IRD COUNTS Invites You To Participate In A Survey

18 March 2019
Source: IRD counts

Inherited Retinal Dystrophies Consortium Operating for the Under-Represented for Novel Therapies and Services IRD COUNTS AND SO DO YOU! HAVE YOUR SAY! YOUR EXPERIENCE IS IMPORTANT! IRD COUNTS Invites You To Participate In A Survey Of Inherited Retinal Disease (IRD) Patients And Those Who Care For Them Have you or someone you know been diagnosed with an IRD? The impact

Read more IRD COUNTS Invites You To Participate In A Survey
IRD Survey Flyer
IRD Survey Flyer
Download pptx 0.6 MB

Fight for Sight: Research to improve survival rates for patients with eye cancer

15 March 2019
Source: Fight for Sight

Fight for Sight is this week announcing research to identify new treatments that could improve survival rates for an eye cancer called uveal melanoma. Researchers from the University of Liverpool will be analysing tumour samples to gain a better understanding about the role of mutation in a gene known as BAP1 in the development of uveal melanoma. The underlying changes

Read more Fight for Sight: Research to improve survival rates for patients with eye cancer

BBC News: Gene therapy first to ‘halt’ AMD the most common cause of blindness

19 February 2019
Source: BBC News

A woman from Oxford has become the first person in the world to have gene therapy to try to halt the most common form of blindness in the Western world. Surgeons injected a synthetic gene into the back of Janet Osborne’s eye in a bid to prevent more cells from dying. It is the first treatment to target the underlying

Read more BBC News: Gene therapy first to ‘halt’ AMD the most common cause of blindness

Macular degeneration trial will be first human test of Nobel-winning stem cell technique

18 January 2019
Source: STAT

Curing diabetes with stem cells? Everyone knew that would be hard. Parkinson’s disease? Harder. Alzheimer’s? Probably impossible. But age-related macular degeneration, a major cause of blindness? That was supposed to be low-hanging fruit. The cause of AMD is well-known, the recipe for turning stem cells into retinal cells works like a charm, and the eye is “immunoprivileged,” meaning immune cells

Read more Macular degeneration trial will be first human test of Nobel-winning stem cell technique